107 related articles for article (PubMed ID: 17483988)
1. Codon Y791F mutations in a large kindred: is prophylactic thyroidectomy always indicated?
Vestergaard P; Vestergaard EM; Brockstedt H; Christiansen P
World J Surg; 2007 May; 31(5):996-1001; discussion 1002-4. PubMed ID: 17483988
[TBL] [Abstract][Full Text] [Related]
2. [Management of multiple endocrine neoplasia syndrome type 2 families in association with rare germline mutations of the RET proto-oncogene].
Fitze G; Saeger HD; Roesner D; Schackert HK
Klin Padiatr; 2004; 216(5):270-6. PubMed ID: 15455293
[TBL] [Abstract][Full Text] [Related]
3. When is prophylactic thyroidectomy indicated for patients with the RET codon 609 mutation?
Calva D; O'Dorisio TM; Sue O'Dorisio M; Lal G; Sugg S; Weigel RJ; Howe JR
Ann Surg Oncol; 2009 Aug; 16(8):2237-44. PubMed ID: 19472011
[TBL] [Abstract][Full Text] [Related]
4. New mutations in the RET protooncogene-L881V - associated with medullary thyroid carcinoma and -R770Q - in a patient with mixed medullar/follicular thyroid tumour.
Frank-Raue K; Döhring J; Scheumann G; Rondot S; Lorenz A; Schulze E; Dralle H; Raue F; Leidig-Bruckner G
Exp Clin Endocrinol Diabetes; 2010 Aug; 118(8):550-3. PubMed ID: 20013610
[TBL] [Abstract][Full Text] [Related]
5. [Clinical diagnosis and treatment of familial medullary thyroid carcinoma caused by a p.C618Y RET proto-oncogene mutation in a Chinese pedigree].
Zhao JQ; Guo L; Qi XP; Chen ZG; Wang KJ; Lou JL; Yu XH; Cheng J; Jin HY; Li XL; Ying RB; Zhang XN
Zhonghua Yi Xue Za Zhi; 2013 Feb; 93(6):440-4. PubMed ID: 23660264
[TBL] [Abstract][Full Text] [Related]
6. New presentation of familial medullary thyroid carcinoma in 87-year-old patient with high-risk RET proto-oncogene codon 620 mutation.
Jaggard MK; MacRae C; Ifeacho S; Robinson S; Tolley NS
J Laryngol Otol; 2009 Jul; 123(7):796-800. PubMed ID: 18771606
[TBL] [Abstract][Full Text] [Related]
7. Long-term follow-up of RET Y791F carriers in Denmark 1994-2017: A National Cohort Study.
Høxbroe Michaelsen S; Ornstrup MJ; Poulsen MM; Bennedbaek FN; Gaustadnes M; Rossing M; Darling P; Vestergaard P; Mathiesen JS
J Surg Oncol; 2019 May; 119(6):687-693. PubMed ID: 30644554
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive assessment of the disputed RET Y791F variant shows no association with medullary thyroid carcinoma susceptibility.
Toledo RA; Hatakana R; Lourenço DM; Lindsey SC; Camacho CP; Almeida M; Lima JV; Sekiya T; Garralda E; Naslavsky MS; Yamamoto GL; Lazar M; Meirelles O; Sobreira TJ; Lebrao ML; Duarte YA; Blangero J; Zatz M; Cerutti JM; Maciel RM; Toledo SP
Endocr Relat Cancer; 2015 Feb; 22(1):65-76. PubMed ID: 25425582
[TBL] [Abstract][Full Text] [Related]
9. When should thyroidectomy be performed in familial medullary thyroid carcinoma gene carriers with non-cysteine RET mutations?
Niccoli-Sire P; Murat A; Rohmer V; Gibelin H; Chabrier G; Conte-Devolx B; Visset J; Ronceray J; Jaeck D; Henry JF; Proye C; Carnaille B; Kraimps JL;
Surgery; 2003 Dec; 134(6):1029-36; discussion 1036-7. PubMed ID: 14668737
[TBL] [Abstract][Full Text] [Related]
10. Familial medullary carcinoma prevention, risk evaluation, and RET in children of families with MEN2.
Moore SW; Appfelstaedt J; Zaahl MG
J Pediatr Surg; 2007 Feb; 42(2):326-32. PubMed ID: 17270543
[TBL] [Abstract][Full Text] [Related]
11. [Prophylactic thyroidectomy in children who are carriers of a multiple endocrine neoplasia type 2 mutation: description of 20 cases and recommendations based on the literature].
de Groot JW; Links TP; Rouwe CW; van der Wal JE; Hofstra RM; Plukker JT
Ned Tijdschr Geneeskd; 2006 Feb; 150(6):311-8. PubMed ID: 16503023
[TBL] [Abstract][Full Text] [Related]
12. Role of prophylactic thyroidectomy in RET 790 familial medullary thyroid carcinoma.
Bihan H; Baudin E; Meas T; Leboulleux S; Al Ghuzlan A; Hannoteaux V; Travagli JP; Valleur P; Guillausseau PJ; Cohen R;
Head Neck; 2012 Apr; 34(4):493-8. PubMed ID: 21688339
[TBL] [Abstract][Full Text] [Related]
13. The clinical spectrum of RET proto-oncogene mutations in codon 790.
Bihan H; Murat A; Fysekidis M; Al-Salameh A; Schwartz C; Baudin E; Thieblot P; Borson-Chazot F; Guillausseau PJ; Cardot-Bauters C; Raingeard I; Requeda E; Sadoul JL; Reznik Y;
Eur J Endocrinol; 2013 Sep; 169(3):271-6. PubMed ID: 23756355
[TBL] [Abstract][Full Text] [Related]
14. Experience of prophylactic thyroidectomy in multiple endocrine neoplasia type 2A kindreds with RET codon 804 mutations.
Learoyd DL; Gosnell J; Elston MS; Saurine TJ; Richardson AL; Delbridge LW; Aglen JV; Robinson BG
Clin Endocrinol (Oxf); 2005 Dec; 63(6):636-41. PubMed ID: 16343097
[TBL] [Abstract][Full Text] [Related]
15. Multiple endocrine neoplasia 2A due to a unique C609S RET mutation presents with pheochromocytoma and reduced penetrance of medullary thyroid carcinoma.
Kinlaw WB; Scott SM; Maue RA; Memoli VA; Harris RD; Daniels GH; Porter DM; Belloni DR; Spooner ET; Ernesti MM; Noll WW
Clin Endocrinol (Oxf); 2005 Dec; 63(6):676-82. PubMed ID: 16343103
[TBL] [Abstract][Full Text] [Related]
16. New era: prophylactic surgery for patients with multiple endocrine neoplasia-2a.
Gosnell JE; Sywak MS; Sidhu SB; Gough IR; Learoyd DL; Robinson BG; Delbridge LW
ANZ J Surg; 2006 Jul; 76(7):586-90. PubMed ID: 16813623
[TBL] [Abstract][Full Text] [Related]
17. [Mutations of ret-proto-oncogene in thyroid medullary carcinoma].
Frank-Raue K; Höppner W; Buhr H; Herfarth C; Ziegler R; Raue F
Dtsch Med Wochenschr; 1997 Feb; 122(6):143-9. PubMed ID: 9081799
[TBL] [Abstract][Full Text] [Related]
18. Mutation analysis of the RET proto-oncogene and early thyroidectomy: results of a Portuguese cancer centre.
Bugalho MJ; Domingues R; Santos JR; Catarino AL; Sobrinho L
Surgery; 2007 Jan; 141(1):90-5. PubMed ID: 17188172
[TBL] [Abstract][Full Text] [Related]
19. Preventive thyroidectomy in patients with hereditary medullary thyroid carcinoma found heterozygote for mutant RET proto-oncogene.
Konstantinou E; Sapsakos Mariolis T; Fotis T; Mitsos A; Restos S; Mamoura K; Soultati A; Elefsiniotis I; Kapellakis G
Pediatr Endocrinol Rev; 2010 Dec; 8(2):108-13. PubMed ID: 21150841
[TBL] [Abstract][Full Text] [Related]
20. Difference in development of medullary thyroid carcinoma among carriers of RET mutations in codons 790 and 791.
Frank-Raue K; Machens A; Scheuba C; Niederle B; Dralle H; Raue F;
Clin Endocrinol (Oxf); 2008 Aug; 69(2):259-63. PubMed ID: 18248648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
